Compare ROL & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ROL | CBOE |
|---|---|---|
| Founded | 1948 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Investment Bankers/Brokers/Service |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 26.8B |
| IPO Year | N/A | 2010 |
| Metric | ROL | CBOE |
|---|---|---|
| Price | $60.52 | $255.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 11 |
| Target Price | $66.20 | ★ $246.64 |
| AVG Volume (30 Days) | ★ 2.4M | 657.3K |
| Earning Date | 02-11-2026 | 02-06-2026 |
| Dividend Yield | ★ 1.20% | 1.13% |
| EPS Growth | 9.81 | ★ 26.68 |
| EPS | 1.06 | ★ 9.30 |
| Revenue | $3,680,306,000.00 | ★ $4,617,800,000.00 |
| Revenue This Year | $12.55 | N/A |
| Revenue Next Year | $9.44 | $5.64 |
| P/E Ratio | $57.07 | ★ $27.54 |
| Revenue Growth | 11.17 | ★ 16.74 |
| 52 Week Low | $45.34 | $187.30 |
| 52 Week High | $61.84 | $262.98 |
| Indicator | ROL | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 54.85 |
| Support Level | $60.27 | $245.34 |
| Resistance Level | $61.10 | $258.07 |
| Average True Range (ATR) | 0.93 | 4.29 |
| MACD | -0.01 | 0.41 |
| Stochastic Oscillator | 79.23 | 78.07 |
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. They also have a litany of other brands, which they use to pursue customers via alternative sales channels. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.